ITM to Host Theranostics Symposium on Clinical Need and Supp

Garching / Munich, June 15, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will host a multidisciplinary symposium titled, “ Investing

Related Keywords

New Jersey , United States , Germany , Munich , Bayern , Canada , German , Canadian , Julia Hofmann Svenja , Ram Mullur , Harshad Kulkarni , Neil Quigley , Radiomolecular Theranostics , Steffen Schuster , Roger Estafanos , Ben Orzelek , Technology Perspective , Canadian Nuclear Laboratories , German Society Of Nuclear Medicine , Theranostics Center , Corporate Communications , Novartis , Chief Medical Advisor , Bold Advanced Medical Future , Global Product Manager , Vice President , Canadian Nuclear , Speaker Details , Advanced Accelerator Applications , Clinical Perspective , Future Utilization , Grand Rapids , Precision Oncology , Zentralklinik Bad Berka , Radiochemical Perspective , Synergy Between , George Von Hevesy Prize , German Society , Nuclear Medicine , Commercial Availability , Radionuclide Therapy , Technologies Munich ,